Suppr超能文献

1型糖尿病微血管变化的无创磁共振成像

Noninvasive magnetic resonance imaging of microvascular changes in type 1 diabetes.

作者信息

Medarova Zdravka, Castillo Gerardo, Dai Guangping, Bolotin Elijah, Bogdanov Alexei, Moore Anna

机构信息

Molecular Imaging Laboratory, MGH/MIT/HMS Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital/Harvard Medical School, Room 2301, Bldg. 149, 13th St., Charlestown, MA 02129, USA.

出版信息

Diabetes. 2007 Nov;56(11):2677-82. doi: 10.2337/db07-0822. Epub 2007 Aug 6.

Abstract

OBJECTIVE

The pathogenesis of type 1 diabetes involves autoimmune lymphocytic destruction of insulin-producing beta-cells and metabolic dysregulation. An early biomarker of pancreatic islet damage is islet microvascular dysfunction, and alterations in vascular volume, flow, and permeability have been reported in numerous models of type 1 diabetes. Consequently, the ability to noninvasively monitor the dynamics of the pancreatic microvasculature would aid in early diagnosis and permit the assessment, design, and optimization of individualized therapeutic intervention strategies.

RESEARCH DESIGN AND METHODS

Here, we used the long circulating paramagnetic contrast agent, protected graft copolymer (PGC) covalently linked to gadolinium-diethylenetriaminepentaacetic acid residues (GdDTPAs) labeled with fluorescein isothiocyanate (PGC-GdDTPA-F), for the noninvasive semiquantitative evaluation of vascular changes in a streptozotocin (STZ)-induced mouse model of type 1 diabetes. Diabetic animals and nondiabetic controls were monitored by magnetic resonance imaging (MRI) after injection of PGC-GdDTPA-F.

RESULTS

Our findings demonstrated a significantly greater accumulation of PGC-GdDTPA-F in the pancreata of diabetic animals compared with controls. MRI permitted the in vivo semiquantitative assessment and direct visualization of the differential distribution of PGC-GdDTPA-F in diabetic and control pancreata. Ex vivo histology revealed extensive distribution of PGC-GdDTPA-F within the vascular compartment of the pancreas, as well as considerable leakage of the probe into the islet interstitium. By contrast, in nondiabetic controls, PGC-GdDTPA-F was largely restricted to the pancreatic vasculature at the islet periphery.

CONCLUSIONS

Based on these observations, we conclude that in the STZ model of type 1 diabetes, changes in vascular volume and permeability associated with early stages of the disease can be monitored noninvasively and semiquantitatively by MRI.

摘要

目的

1型糖尿病的发病机制涉及产生胰岛素的β细胞的自身免疫性淋巴细胞破坏和代谢失调。胰岛微血管功能障碍是胰岛损伤的早期生物标志物,并且在众多1型糖尿病模型中均已报道血管容量、血流和通透性的改变。因此,无创监测胰腺微血管动力学的能力将有助于早期诊断,并允许对个体化治疗干预策略进行评估、设计和优化。

研究设计与方法

在此,我们使用与异硫氰酸荧光素标记的钆-二乙烯三胺五乙酸残基(GdDTPAs)共价连接的长循环顺磁性造影剂——保护接枝共聚物(PGC)(PGC-GdDTPA-F),对链脲佐菌素(STZ)诱导的1型糖尿病小鼠模型中的血管变化进行无创半定量评估。在注射PGC-GdDTPA-F后,通过磁共振成像(MRI)对糖尿病动物和非糖尿病对照进行监测。

结果

我们的研究结果表明,与对照相比,糖尿病动物胰腺中PGC-GdDTPA-F的蓄积明显更多。MRI允许对PGC-GdDTPA-F在糖尿病和对照胰腺中的差异分布进行体内半定量评估和直接可视化。离体组织学显示PGC-GdDTPA-F在胰腺血管腔内广泛分布,并且探针大量渗漏到胰岛间质中。相比之下,在非糖尿病对照中,PGC-GdDTPA-F主要局限于胰岛周边的胰腺血管。

结论

基于这些观察结果,我们得出结论,在1型糖尿病的STZ模型中,与疾病早期相关的血管容量和通透性变化可通过MRI进行无创半定量监测。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验